Skip to main content

ONO PHARMACEUTICAL CO., LTD.

  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • About
     

    About
    Top

    • About Top
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • History
    • Main Products
    • Videos and Advertisements
    • Policies / Guidelines
    Business Activities
    • R&D
    • Manufacturing
    • Marketing
    • Safety and Quality Assurance
  • R&D
     

    R&D
    Top

    • R&D Top
    • Our Mission in R&D / Drug Discovery Approach
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Organization
    • Development Pipeline
  • Global Business
  • Sustainability
     

    Sustainability
    Top

    • Sustainability Top
    • Top message
    • ONO's Approach to CSR
    • Governance
    • Society
    • Environment
    • Social Contribution Activities
    • Policies
    • GRI Content Index
    • CSR Report Download
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
icon_search_white icon_close_w
  • About
    • About Top
    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • History
    • Main Products
    • Videos and Advertisements
    • Policies / Guidelines
    Business Activities
    • R&D
    • Manufacturing
    • Marketing
    • Safety and Quality Assurance
  • R&D
    • R&D Top
    • Our Mission in R&D / Drug Discovery Approach
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Organization
    • Development Pipeline
  • Global Business
    • Global Business Top
  • Sustainability
    • Sustainability Top
    • Top message
    • ONO's Approach to CSR
    • Governance
    • Society
    • Environment
    • Social Contribution Activities
    • Policies
    • GRI Content Index
    • CSR Report Download
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
icon_search_g
Home News

News

  • Press Releases
  • Notices
  • Corporate
  • Management / Finance

2020.

  • Sep.18.2020 Corporate
    Announcement on posting of Corporate Report 2020
  • Jun.19.2020 Corporate
    Voting Results (Extraordinary Report) of the 72nd Ordinary General Shareholders' Meeting
  • Jun.18.2020 Corporate
    Notice to Resolutions Passed at The 72nd Ordinary General Shareholders' Meeting
  • May.21.2020 Corporate
    Notice to Convene the 72nd Ordinary General Shareholders' Meeting

2019.

  • Oct.24.2019 Corporate
    Discontinuation of RSS Feeds(40 KB)
  • Oct.15.2019 Corporate
    IR Library has been redesigned.
  • Aug.29.2019 Corporate
    Announcement on posting of Corporate Report 2019
  • May.23.2019 Corporate
    Notice to Convene the 71st Ordinary General Shareholders' Meeting

2018.

  • Sep.03.2018 Corporate
    Announcement on posting of Corporate Report 2018
  • Jun.22.2018 Corporate
    Notice of Resolutions Passed at The 70th Ordinary General Shareholders' Meeting
  • May.25.2018 Corporate
    Notice to Convene the 70th Ordinary General Shareholders' Meeting

2017.

  • Aug.31.2017 Corporate
    Announcement on posting of Corporate Report 2017
  • Jun.29.2017 Corporate
    Notice of Resolutions Passed at The 69th Ordinary General Shareholders' Meeting
  • Jun.01.2017 Corporate
    Notice to Convene the 69th Ordinary General Shareholders' Meeting
  • Feb.06.2017 Corporate
    Certain Media Coverage Related to ONO Reported on February 4(50 KB)
  • About

    About

    • Greetings
    • Mission Statement
    • Corporate Governance
    • Management Strategy
    • ONO Story
    • Company Overview
    • Business Activities
    • History
    • Main Products
    • Videos and Advertisements
    • Policies / Guidelines
  • R&D

    R&D

    • Our Mission in R&D / Drug Discovery Approach
    • In-house Drug Discovery
    • Open Innovation
    • Licensing Activities
    • Research Organization
    • Development Organization
    • Development Pipeline
  • Global Business

    Global Business

  • Sustainability

    Sustainability

    • Top message
    • ONO's Approach to CSR
    • Governance
    • Society
    • Environment
    • Social Contribution Activities
    • Policies
    • GRI Content Index
    • CSR Report Download
    • ESG Data
    • External Evaluation
    • Independent Practitioner's Assurance
  • Investors
  • News
  • Contact
  • Japanese
  • Global
  • Privacy Policy
  • Terms of Use
  • Site Map

COPYRIGHT © 2021 ONO PHARMACEUTICAL CO., LTD.
ALL RIGHTS RESERVED.

GoTo Top